Prognostic Markers of Patients With STEMI

Completed

• Conditions: STEMI - ST Elevation Myocardial Infarction

• Registration Number: NCT03527940
• Lead Sponsor: Chongqing Medical University

Brief Summary

To analyze the relationship between the clinical data and the outcomes of STEMI patients.

Detailed Description

Not available

Study Timeline

• Study Start: 2015-09-17
• Study First Submitted: 2018-05-05
• Study First Submitted QC: 2018-05-05
• Study First Posted: 2018-05-17
• Primary Completion: 2019-07-01
• Study Completion: 2020-01-01
• Status Verified: 2020-03
• Last Update Submitted: 2020-03-01
• Last Update Posted: 2020-03-04

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 932

Inclusion Criteria

• Patients diagnosed with ST-segment elevation myocardial infarction(STEMI).

Exclusion Criteria

• Patients with concurrent infection or any documented inflammatory illness, such as arthritis or connective tissue diseases,or any other malignancy.
• Pregnant women.
• Severe hepatic dysfunction.
• Uncontrolled hypertension.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
All cause mortality	3 years

Trial Locations

Locations (1)

The First Affiliated Hospital of Chongqing Medical University; 🇨🇳 Chongqing, Chongqing, China